Getinge AB (publ) ( GNGBY) - Stock Earnings
GNGBY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 17, 2026, midnight | — / — | — | — / — | — |
GNGBY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 94.3 million USD | 1.1 billion USD |
| 2026Q1 | 41.9 million USD | 777.5 million USD |
| 2026Q2 | 86.6 million USD | 863.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GNGBY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 239.5 million USD | 3.2 billion USD |
| 2024 | 148.9 million USD | 3.2 billion USD |
| 2025 | 245.2 million USD | 3.8 billion USD |
| 2026 Est. | — | — |
GNGBY
Price: $23.89
Dividend Yield: 2.12%
Forward Dividend Yield: 1.18%
Payout Ratio: 45.26%
Dividend Per Share: 0.28 USD
Earnings Per Share: 1.01 USD
P/E Ratio: 23.94
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Country: Sweden
Volume: 7753
Ebitda: 698.1 millionMarket Capitalization: 6.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16
DGR3: 6.00%
DGR5: 30.00%
DGR10: 27.89%